Sudarshan Pharma Falls 9.16% Amid Downgrade and Mixed Technical Signals
2026-11-21 11:02:37Key Events This Week 16 Nov: Week opens at Rs.32.21, initial decline begins 17 Nov: Downgrade to Sell announced amid debt and earnings concerns 18 Nov: Technical momentum shifts amid mixed indicators 20 Nov: Sharp drop to Rs.29.76 closes the week down 9.16% Week OpenRs.32.76 Week CloseRs.29.76<...
Read More
Sudarshan Pharma Industries Ltd Technical Momentum Shifts Amid Mixed Indicators
2026-11-18 08:05:52Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s mixed technical indicators suggest a complex outlook for investors navigating its price movements and market positioning.
Read More
Sudarshan Pharma Industries Ltd Downgraded to Sell Amid Debt Concerns and Flat Quarterly Performance
2026-11-17 09:07:52Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has been downgraded from Hold to Sell by MarketsMOJO as of 16 Nov 2026. The revision reflects a deteriorating debt servicing capacity amid flat quarterly financials, despite healthy long-term growth and attractive valuation metrics. This comprehensive analysis explores the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change.
Read More
Sudarshan Pharma Industries Ltd is Rated Hold by MarketsMOJO
2026-11-14 10:10:28Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date analysis of the company’s performance and outlook.
Read More
Sudarshan Pharma Industries Ltd Locks at Lower Circuit With 7.48% Loss — Sellers Queue, No Buyers in Sight
2026-11-03 15:00:09At Rs 32.53, Sudarshan Pharma Industries Ltd locked at its lower circuit limit of 7.48% on 03 Nov 2026, with persistent unfilled supply as sellers outnumbered buyers and the price froze at the floor level.
Read More
Sudarshan Pharma Industries Ltd is Rated Hold
2026-11-01 10:10:33Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Sudarshan Pharma Industries Ltd Reports Strong Quarterly Growth Amid Market Volatility
2026-10-30 11:00:29Sudarshan Pharma Industries Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, signalling a positive shift in its growth trajectory. The company’s revenue and profit metrics have expanded significantly compared to previous quarters, reflecting operational efficiencies and robust demand in the specialty chemicals sector.
Read More
Sudarshan Pharma Industries Ltd is Rated Hold
2026-10-21 10:10:38Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Sudarshan Pharma Industries Ltd is Rated Hold
2026-10-10 10:10:35Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 October 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
09-Nov-2026 | Source : BSEPursuant to Regulation 30 and other applicable Regulations if any of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we inform you that Mr. Nirav Shah has resigned as the Company Secretary and Compliance Officer of the Company with effect from 9/Nov/2026.
Announcement under Regulation 30 (LODR)-Investor Presentation
07-Nov-2026 | Source : BSEIn terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 we hereby submit the updated Investor Presentation.
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSEPlease find enclosed herewith the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half yearly ended 30/Sept/2026 published in the following newspapers:
Corporate Actions
No Upcoming Board Meetings
Sudarshan Pharma Industries Ltd has declared 3% dividend, ex-date: 25 Aug 23
Sudarshan Pharma Industries Ltd has announced 1:10 stock split, ex-date: 22 Nov 24
No Bonus history available
No Rights history available